In addition to its presumed anti-inflammatory effects through acting on TAS2R and A2aR (and thus contributing to mitigating HCC pathogenesis) (36), caffeine probably also has unknown anticancer effects through activation of TAS2Rs. Here, ADORA2A is linked to hepatocellular carcinoma.